SCHEMBL31729367

SCHEMBL31729367

COCc1nn(C)c2nc(Cl)ncc12

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 3/20 0.35
LRRK2 Q5S007 2/20 0.33
GAA P10253 1/20 0.32
KDM4E B2RXH2 2/20 0.31
ALDH1A1 P00352 2/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
LMNA P02545 1/20 0.31
MAPK1 P28482 1/20 0.31
NR3C1 P04150 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14192196 0.83 PDE2A (0.37) PDE2ALRRK2GAASMN1; SMN2NR3C1
SCHEMBL30968152 0.76 PDE2A (0.39) PDE2AGAAKDM4EALDH1A1SMN1; SMN2
SCHEMBL8089905 0.74 PDE2A (0.40) PDE2AGAASMN1; SMN2NR3C1KMT2A
SCHEMBL30259549 0.72 PDE2A (0.39) PDE2AGAASMN1; SMN2KMT2ACYP1A2
SCHEMBL26527418 0.72 PDE2A (0.39) PDE2AGAASMN1; SMN2KMT2ACYP1A2
SCHEMBL31729399 0.72 PDE2A (0.36) PDE2AGAAKMT2AMEN1
SCHEMBL31728695 0.70 CSNK1A1 (0.39) PDE2AGAAKDM4EALDH1A1SMN1; SMN2
SCHEMBL29345860 0.70 HSD17B10 (0.37) KDM4EALDH1A1LMNAMAPK1NPC1
SCHEMBL31729103 0.69 PDE2A (0.36) PDE2AGAAKMT2A
SCHEMBL31729408 0.69 PDE2A (0.36) PDE2AGAASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235331-A1 BIFUNCTIONAL COMPOUNDS CONTAINING PYRAZOLOPYRIMIDINE DERIVATIVES FOR DEGRADING CERTAIN CYCLIN-DEPENDENT KINASE VIA UBIQUITIN PROTEASOME PATHWAY NIKANG THERAPEUTICS, INC. (US) 2025-11-13 WO disclosed